Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer
Emily M.J. Fennell(University of North Carolina at Chapel Hill), Lee M. Graves(University of North Carolina at Chapel Hill)
Cited by 20
Related Papers
Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
|Molecular Pharmacology|2010|74
Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia
|PLoS ONE|2013|73
Mass spectrometry–based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
|Journal of Biological Chemistry|2020|30
BIRC6 mediates imatinib resistance independently of Mcl-1
|PLoS ONE|2017|19